XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2023
Stockholders’ Equity [Abstract]  
Schedule of restricted common stock The Company’s activity in restricted Common Stock was as follows for the six months ended June 30, 2023:
   Number of shares   Weighted
average
grant date
fair value		 
Non–vested at January 1, 2023   
-
   $
-
 
Granted   11,088   $8.16 
Vested   (11,088)  $8.16 
Non–vested at June 30, 2023   
-
   $   
The Company’s activity in RSUs was as follows for the six months ended June 30, 2023:
   Number of shares   Weighted average
grant date fair value		 
Non–vested at January 1, 2023   134,799   $28.74 
Granted   108,571   $14.17 
Vested   (70,797)  $27.31 
Forfeited   (8,651)  $14.80 
Non–vested at June 30, 2023   163,922   $20.44 
Schedule of warrant activity The Company’s warrant activity was as follows for the six months ended June 30, 2023:
   Number of Shares   Weighted Average Exercise Price (USD)   Weighted Average Contractual Life (years)   Intrinsic Value
(USD)		 
Outstanding - January 1, 2023   2,003,649   $149.09    2.86   $
-
 
Outstanding – June 30, 2023   2,003,649   $149.09    2.36   $
-
 
Exercisable – June 30, 2023   2,003,649   $149.09    2.36   $
-
 

 
Schedule of the fair value of series C warrants in connection The following assumptions were used to calculate the fair value of Series C Warrants in connection with the modifications:
   Original
Series C
Warrants		   March 1,
2022
Modification		   November 7,
2022
Modification		 
Term (years)   3.8    5.0    3.1 
Stock price  $22.22   $22.22   $14.52 
Exercise price  $30.80   $30.80   $12.77 
Dividend yield   0.0%   0.0%   0.0%
Expected volatility   54.7%   50.8%   63.9%
Risk free interest rate   1.5%   1.5%   4.8%
Number of shares   455,867    455,867    455,867 
Aggregate fair value  $3,336,000   $3,648,000   $3,230,000 

 

The following assumptions were used to calculate the fair value of Series D Warrants in connection with the modifications:
   Original
Series D
Warrants		   March 1,
2022
Modification		   November 7,
2022
Modification		 
Term (years)   3.8    3.8    3.1 
Stock price  $22.22   $22.22   $14.52 
Exercise price  $151.80   $151.80   $12.77 
Dividend yield   0.0%   0.0%   0.0%
Expected volatility   63.5%   50.8%   63.9%
Risk free interest rate   1.3%   1.6%   4.8%
Number of shares   111,321    111,321    111,321 
Aggregate fair value  $50,000   $138,000   $910,000